Blockchain Systems in Pharmaceuticals
Transform Quality and Compliance


Thursday, July 30, 2020 • 1:30 p.m. - 3:30 p.m. EDT

Bewildered by blockchain? You’re not alone.

Understand the core tenets of distributed systems, blockchains and cryptography and you’ll transform your quality and compliance processes by increasing efficiency and improving security.

James Canterbury — a partner in Ernst & Young’s Risk Advisory practice where he works with the global blockchain team — will explain how blockchains work.

Blockchains keep track of individual medical product transactions — from concept through postmarket surveillance and even the supply chain — in linked groups called blocks. When an authorized user changes information, a new block is created along with indicators that show exactly what changes were made from the previous version and when they were made. Immediately, all new information is disseminated to every authorized user.

Because information can never be written over — similar to a Microsoft Word document with the tracked changes feature on permanently — there is always a tamper-proof log of activity that is highly efficient and much more resilient to cyberattacks and fraud than a traditional database.

Webinar Takeaways:

  • Highlights of where blockchains are currently being used in the pharmaceutical industry, including manufacturing and the supply chain

  • The core components of blockchain technology, including single-source data integrity

  • Public vs. private blockchains and the challenges, advantages and disadvantages of each

  • How to use a blockchain as a notarization system

  • The role of non-fungible tokens in product track and trace in the COVID-19 era and beyond 

Put blockchain to work for your company to streamline processes, improve quality, ensure compliance and simplify data integrity. Join us by registering today.

Webinar plus Recording & Transcript Bundle
Learn more

$487

add to cart

Webinar only
Learn more

$287

add to cart

24/7 Encore plus Recording & Transcript Bundle
Learn more

$487

add to cart

24/7 Encore Presentation
Learn more

$287

add to cart

Webinar Recording & Transcript Bundle
Learn more

$287

add to cart

 

Who Will Benefit

  • Quality Specialists
  • Regulatory Specialists
  • Compliance Specialists
  • Data Integrity Professionals
  • Vice Presidents of Strategic Planning

 

Meet Your Presenter

James Canterbury

Partner
Ernst & Young’s Risk Advisory

James Canterbury is a partner in Ernst & Young’s Risk Advisory practice where he works with the global blockchain team to develop technology solutions for life sciences companies. Mr. Canterbury is also on the board of directors for the global good automated manufacturing practice (GAMP) steering committee as part of the International Society of Pharmaceutical Engineers, where he leads the GAMP Blockchain special interest group.

MII logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 | Fax 703.538.7676 | Toll free 888.838.5578 | Email customerservice@fdanews.com

© 2020 FDAnews